Schonfeld Strategic Advisors LLC Neogenomics Inc Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 57,440 shares of NEO stock, worth $759,356. This represents 0.01% of its overall portfolio holdings.
Number of Shares
57,440Holding current value
$759,356% of portfolio
0.01%Shares
7 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$260 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$187 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$116 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$89 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$87.5 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.66B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...